Inventor profile of:

Bertolt Kreft

City:

Kleinmachnow

Country:

Germany

Published Applications:

20

Last publication date:

2026-07-02

Top Assignees for applications by Bertolt Kreft

The entities that hold a legal rights for patent applications filed by inventor Kreft Bertolt:

Recent patent applications by Kreft Bertolt

Bertolt Kreft from Kleinmachnow, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-07-02
US20260184792A1
Chemistry; metallurgy

TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS

#2 | 2026-05-21
US20260139053A1
Chemistry; metallurgy

TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS

#3 | 2025-07-03
US20250213705A1
Human necessities

PSMA TARGETING LIGANDS AND METHODS OF USE

#4 | 2025-06-19
US20250197467A1
Chemistry; metallurgy

ACTIVATABLE IL-18 IMMUNOCYTOKINES AND USES THEREOF

#5 | 2025-06-12
US20250188166A1
Chemistry; metallurgy

IL-18 POLYPEPTIDES FUSED TO IMMUNE CELL ANTIGEN SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

#6 | 2025-06-12
US20250186597A1
Human necessities

TARGETED IMMUNE ACTIVATION WITH IL-18 IMMUNOCYTOKINES

#7 | 2025-06-12
US20250186594A1
Human necessities

IL-18 POLYPEPTIDES MODIFIED WITH POLYMERS

#8 | 2024-12-26
US20240424127A1
Human necessities

IL-7 POLYPEPTIDES, IMMUNOCYTOKINES COMPRISING SAME, AND USES THEREOF

#9 | 2024-12-19
US20240417436A1
Chemistry; metallurgy

CONDITIONALLY ACTIVATED IMMUNOCYTOKINES AND METHODS OF USE

#10 | 2024-12-05
US20240400614A1
Chemistry; metallurgy

CLEAVABLE PEPTIDES AND METHODS OF USE THEREOF

#11 | 2024-11-14
US20240376170A1
Chemistry; metallurgy

CONDITIONALLY ACTIVATED PROTEINS AND METHODS OF USE

#12 | 2024-05-16
US20240158537A1
Chemistry; metallurgy

SYNTHETIC IL-7 AND IL-7 IMMUNOCYTOKINES

#13 | 2023-09-28
US20230303649A1
Chemistry; metallurgy

MODIFIED IL-2 POLYPEPTIDES FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

#14 | 2023-08-10
US20230250181A1
Chemistry; metallurgy

MODIFIED CHECKPOINT INHIBITORS AND USES THEREOF

#15 | 2023-06-29
US20230201365A1
Human necessities

MODIFIED CD20 ANTIBODIES AND USES THEREOF

#16 | 2023-06-29
US20230201364A1
Human necessities

ANTIBODY CONJUGATES AND MANUFACTURE THEREOF

#17 | 2023-06-15
US20230183331A1
Chemistry; metallurgy

Modified TNF-α antibodies and uses thereof

#18 | 2023-06-15
US20230181754A1
Human necessities

MODIFIED CHECKPOINT INHIBITORS AND USES THEREOF

#19 | 2022-02-24
US20220056091A1
Chemistry; metallurgy

MODIFIED IL-18 POLYPEPTIDES AND USES THEREOF

#20 | 2012-05-24
US20120128662A1
Chemistry; metallurgy

Substituted imidazoquinoxalines

InventorID:

3174901 ⎘